CytomX Therapeutics Inc.
CTMX | NASDAQ
$2.79
+$0.03 (+1.09%)
Sep 22, 2026, 10:57 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -38.91M | -18.25M | -26.51M | -14.23M | -154K | 23.53M | 18.88M | 5.74M | -6.53M | 13.79M | 837K | 2.99M | -1.09M | -3.31M | -8.78M | -23.3M | -24.18M | -31.98M | -26.23M | -22.58M | -19.24M | -15.55M |
Depreciation & Amortization | 298K | 37K | 510K | 134K | 347K | 385K | 413K | 429K | 459K | 467K | 486K | 1.43M | 1.53M | 595K | 1.49M | 623K | 1.45M | 602K | 1.48M | 1.47M | 1.45M | 674K |
Stock-Based Compensation | 7.28M | 4.71M | 1.48M | 1.38M | 1.43M | 2.01M | 1.88M | 2M | 1.88M | 1.91M | 2.55M | 1.23M | 2.37M | 2.41M | 2.57M | 2.7M | 4.49M | 3.37M | 3.54M | 3.16M | 3.43M | 3.03M |
Other Working Capital | 22.22M | -14.1M | 163K | -3.99M | -18.13M | -47.93M | -41.45M | -28.94M | -23.9M | -32.17M | -23.24M | -22.11M | -24.3M | -23.99M | 58.83M | -17.3M | -16.14M | -12.82M | 20.97M | -11.62M | -12.92M | -18.74M |
Other Non-Cash Items | 343K | 620K | 844K | 497K | 711K | 627K | 376K | -188K | -429K | -880K | -1.26M | -707K | 646K | -634K | -16.36M | 848K | 4.47M | 809K | -28.73M | 3.17M | 3.57M | 900K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -12.63M | -12.66M | 434K | -3.33M | -18.09M | -47.59M | -41.46M | -28.7M | -14.93M | -41.33M | -24.58M | -21.95M | -26.27M | 10.29M | 22.25M | -14.71M | -15.98M | -14.11M | 22.29M | -11.76M | -13.97M | -18.99M |
Operating Cash Flow | -43.62M | -25.55M | -23.24M | -15.55M | -15.75M | -21.04M | -19.91M | -20.73M | -19.55M | -26.05M | -21.96M | -18.24M | -25.18M | 9.35M | -1.39M | -33.84M | -34.24M | -41.31M | -31.19M | -29.7M | -28.2M | -29.94M |
Capital Expenditures | n/a | n/a | -201K | 127K | -27K | -119K | -80K | -19K | -96K | -115K | -266K | -9K | -517K | -48K | -182K | -410K | -412K | -736K | -245K | -268K | -114K | -982K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -311.82M | -242.78M | -44.22M | -19.69M | -108.83M | -19.79M | -49.78M | -12.31M | -93.39M | n/a | -111.87M | -92.93M | -73.44M | -146.59M | n/a | n/a | n/a | n/a | n/a | n/a | -99.9M | n/a |
Sales Maturities Of Investments | 125M | 50M | 30M | 20M | 32.5M | 50.5M | 65M | 30.5M | 115M | 45M | 125M | 50M | 100M | n/a | 100M | n/a | n/a | n/a | n/a | 10M | 54M | 59.99M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -186.82M | -192.78M | -14.42M | 439K | -76.36M | 30.6M | 15.14M | 18.17M | 21.51M | 44.89M | 12.87M | -42.94M | 26.04M | -146.64M | 99.82M | -410K | -412K | -736K | -245K | 9.73M | -46.01M | 59.01M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | 183K | n/a | n/a | n/a | 244K | n/a | n/a | n/a | n/a | n/a | n/a | 7K | n/a | n/a | -107.6M | 1.02M |
Financial Cash Flow | 235M | 234.49M | 16.64M | 253K | 93.55M | n/a | 2.25M | n/a | 5.1M | 174K | 244K | 29.67M | 317K | n/a | 190K | n/a | 451K | 7K | 683K | 104K | 691K | 108.74M |
Net Cash Flow | 4.56M | 16.16M | -21.02M | -14.86M | 1.44M | 9.55M | -2.52M | -2.56M | 7.06M | 19.01M | -8.85M | -31.51M | 1.18M | -137.29M | 98.61M | -34.25M | -34.2M | -42.04M | -30.75M | -19.86M | -73.52M | 137.81M |
Free Cash Flow | -43.62M | -25.55M | -23.44M | -15.42M | -15.78M | -21.16M | -19.99M | -20.75M | -19.65M | -26.16M | -22.23M | -18.25M | -25.7M | 9.3M | -1.58M | -34.25M | -34.65M | -42.05M | -31.44M | -29.97M | -28.31M | -30.92M |
Adj. Free Cash Flow | -50.9M | -30.26M | -24.92M | -16.81M | -17.21M | -23.17M | -21.87M | -22.74M | -21.53M | -28.07M | -24.78M | -19.48M | -28.07M | 6.89M | -4.15M | -36.95M | -39.14M | -45.42M | -34.98M | -33.13M | -31.74M | -33.96M |
Maintenance CapEx | n/a | n/a | -201K | 127K | -27K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -46.47K | -410K | -412K | -736K | n/a | -268K | -114K | -982K |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | -119K | -80K | -19K | -96K | -115K | -266K | -9K | -517K | -48K | -135.53K | n/a | n/a | n/a | -245K | n/a | n/a | n/a |
Owner Earnings | -43.62M | -25.55M | -23.44M | -15.42M | -15.78M | -21.04M | -19.91M | -20.73M | -19.55M | -26.05M | -21.96M | -18.24M | -25.18M | 9.35M | -1.44M | -34.25M | -34.65M | -42.05M | -31.19M | -29.97M | -28.31M | -30.92M |
Add to Watchlist
Select watchlists to add or remove CTMX